Insight Molecular Diagnostics Inc. (IMDX) Executive Compensation
Insight Molecular Diagnostics Inc. (IMDX) is a publicly traded company on the Nasdaq, categorized under SIC 2835 (In Vitro & In Vivo Diagnostic Substances). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: IMDX
CIK: 1642380
Exchange: Nasdaq
SIC 2835: In Vitro & In Vivo Diagnostic Substances
Fiscal Year End: 12/31
State: CA
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
CBIZ CPAs P.C.
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerJoshua Pena
Audit LocationCosta Mesa, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-09-21 | 2026-09-15 | 8-K | 0001493152-26-043560 | View SEC Doc Filr Page |
| 10-Q | 2026-08-10 | 2026-06-30 | 10-Q | 0001642380-26-000011 | View SEC Doc Filr Page |
| 8-K | 2026-08-10 | 2026-08-10 | 8-K | 0001493152-26-036863 | View SEC Doc Filr Page |
| S-8 | 2026-07-24 | — | S-8 | 0001493152-26-034564 | View SEC Doc Filr Page |
| 4 | 2026-07-06 | 2026-07-01 | 4 | 0001493152-26-032235 | View SEC Doc Filr Page |
| 4 | 2026-07-06 | 2026-07-01 | 4 | 0001493152-26-032233 | View SEC Doc Filr Page |
| 4 | 2026-07-06 | 2026-07-01 | 4 | 0001493152-26-032231 | View SEC Doc Filr Page |
| 8-K | 2026-06-17 | 2026-06-11 | 8-K | 0001493152-26-029078 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | 4 | 0001493152-26-028755 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | 4 | 0001493152-26-028754 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | 4 | 0001493152-26-028753 | View SEC Doc Filr Page |
| 10-Q | 2026-05-13 | 2026-03-31 | 10-Q | 0001642380-26-000008 | View SEC Doc Filr Page |
| 8-K | 2026-05-13 | 2026-05-13 | 8-K | 0001493152-26-022721 | View SEC Doc Filr Page |
| 8-K/A | 2026-05-13 | 2026-02-20 | 8-K/A | 0001493152-26-022708 | View SEC Doc Filr Page |
| ARS | 2026-04-30 | 2025-12-31 | ARS | 0001493152-26-020532 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-30 | — | DEFA14A | 0001493152-26-020518 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-30 | 2026-04-30 | DEF 14A | 0001493152-26-020502 | View SEC Doc Filr Page |
| 8-K | 2026-04-30 | 2026-04-30 | 8-K | 0001493152-26-020461 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-04-27 | — | SCHEDULE 13D/A Filing | 0000919574-26-002415 | View SEC Doc Filr Page |
| 4 | 2026-04-27 | 2026-04-23 | 4 Filing | 0000919574-26-002414 | View SEC Doc Filr Page |
| 4 | 2026-04-20 | 2026-04-16 | 4 Filing | 0000919574-26-002306 | View SEC Doc Filr Page |
| 4 | 2026-03-30 | 2026-03-26 | 4 Filing | 0001493152-26-013574 | View SEC Doc Filr Page |
| 4 | 2026-03-30 | 2026-03-26 | 4 | 0001493152-26-013572 | View SEC Doc Filr Page |
| 4 | 2026-03-30 | 2026-03-26 | 4 Filing | 0001493152-26-013571 | View SEC Doc Filr Page |
| 10-K | 2026-03-26 | 2025-12-31 | 10-K | 0001642380-26-000004 | View SEC Doc Filr Page |